Advanced cell therapeutics are changing the clinical landscape: will mesenchymal stromal cells be a part of it?
Abstract During the past 15 years there have been dramatic changes in the medical landscape, particularly in oncology and regenerative medicine. Cell therapies have played a substantial part in this progress. Cellular immunotherapies can use immune cells, such as T cells or natural killer cells that...
Main Author: | Richard Schäfer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-019-1289-6 |
Similar Items
-
Comparison of endometrial regenerative cells and bone marrow stromal cells
by: Wang Huan, et al.
Published: (2012-10-01) -
Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration
by: Georgy D. Sagaradze, et al.
Published: (2020-09-01) -
Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine
by: Vitale Miceli, et al.
Published: (2021-01-01) -
Characterisation of mesenchymal stromal cells in clinical trial reports: analysis of published descriptors
by: Alison J. Wilson, et al.
Published: (2021-06-01) -
Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
by: Meryem Ouzin, et al.
Published: (2023-08-01)